News & Updates

A survey evaluating paediatric oncology nurses from KK Women’s and Children’s Hospital reveals that they may not be well-versed in terms of oral health knowledge.

The oral, small molecule Wee1 kinase inhibitor adavosertib exerts antitumour effects in patients with advanced recurrent or persistent uterine serous carcinoma, but this benefit appears to be limited by the drug’s tolerability, as shown in the single-arm, phase IIb ADAGIO study.

In the EPI-VITRAKVI study, the TRK* inhibitor larotrectinib reduces morbidity and the need for aggressive local therapies in children with infantile fibrosarcoma (IFS) compared with the current standard of care (SoC).

A recent study on patients with extraskeletal myxoid chondrosarcoma (EMC) reports a high rate of recurrence, high propensity for metastasis, and high rate of progression of metastatic disease on systemic therapy.

Radiation treatment boasts of high locoregional control of anal margin cancer, as well as positive outcomes in the long term, according to a study.